Cytokine release syndrome: Inflammatory signaling, panoptosis, and therapeutic perspectives.
Cytokine release syndrome (CRS) is a major limitation of current immunotherapy. Inflammatory complications are prone to occur after chimeric antigen receptor T-cell therapy and other immune-binding strategies. Cytokine overproduction is a well-defined feature of CRS. Yet the progression of CRS involves a complex interp...